Estimates

Analyst Ratings

1-Strong Buy	7
2-Buy	5
3-Hold	12
4-Underperform	0
5-Sell	0

Mean Recommendation: 2.3
Sell		Strong Buy

Analyst Forecasts - EPS
							Last Month Revisions
Fiscal Period		Mean	High	Low	Median	# of Estimates	#Up	#Down	Mean % Change
Annual	Apr 15	4.11	4.21	3.98	4.12	18	0	5	-0.39
Annual	Apr 14	3.84	4.00	3.72	3.83	25	0	7	-0.29
Annual	Apr 13	3.69	3.73	3.67	3.69	25	0	4	-0.04
Quarterly	Apr 13	1.03	1.04	1.01	1.03	23	0	2	-0.08
Quarterly	Jul 13	0.90	0.93	0.87	0.90	18	1	2	-0.06
Quarterly	Oct 13	0.93	0.97	0.90	0.93	18	0	3	-0.06
Quarterly	Jan 14	0.93	0.96	0.90	0.92	17	0	4	-0.25
Long Term Growth		6.52	7.70	5.39	6.45	8	1	0	0.78

Actuals - EPS
		Reported EPS	Mean Estimate	Surprise % Change
Annual	Apr 12	3.46	3.45	0.41
Quarterly	Apr 12	0.99	0.98	1.06
Quarterly	Jul 12	0.85	0.85	0.00
Quarterly	Oct 12	0.88	0.88	-0.33
Quarterly	Jan 13	0.93	0.91	1.75
Annual	Apr 11	3.37	3.39	-0.71
Annual	Apr 10	3.23	3.21	0.58

Data Provided by Thomson Reuters

Disclaimer: Average earnings estimates are calculated by First Call based on the earnings projections made by the analysts who cover Medtronic, Inc. Please note that any opinions, estimates or forecasts regarding Medtronic, Inc.'s performance made by these analysts, including their average estimate numbers, are theirs alone and do not represent opinions, forecasts or predictions of Medtronic, Inc. or its management. Medtronic, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. Our actual earnings may differ materially from those above, and our earnings are subject to risks and uncertainties such as those described in Medtronic's Annual Report on Form 10-K filed with the Securities and Exchange Commission.

Medtronic

Estimates

Section Navigation